2007
DOI: 10.1007/s00432-007-0329-3
|View full text |Cite
|
Sign up to set email alerts
|

Kaposi’s sarcoma after liver transplantation

Abstract: KS should be treated by a multidisciplinary approach to obtain an early diagnosis and best management. Effective treatment with immunosuppression reduction or switch to sirolimus is mandatory and can induce complete regression.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
34
0
2

Year Published

2009
2009
2019
2019

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(36 citation statements)
references
References 24 publications
0
34
0
2
Order By: Relevance
“…Distinct from most other European studies [16], [17], [18] with the exception of the series of Collett and Al. (19), the follow-up of our patients is quite long, as our first liver transplant was performed in 1983, allowing a broader perspective on this problem.…”
Section: Discussionmentioning
confidence: 69%
See 1 more Smart Citation
“…Distinct from most other European studies [16], [17], [18] with the exception of the series of Collett and Al. (19), the follow-up of our patients is quite long, as our first liver transplant was performed in 1983, allowing a broader perspective on this problem.…”
Section: Discussionmentioning
confidence: 69%
“…In immunocompetent subjects, cervical cancer has been linked to Human Papilloma Virus infections, and Kaposi's sarcoma with Human Herpes Virus 8. Infection with Epstein Barr Virus is the main risk factor for developing lymphoproliferative disorders [12], [13], [18], nasopharyngeal cancer and some types of leiomyosarcoma. HCV has a controversial role [12].…”
Section: Discussionmentioning
confidence: 99%
“…Kaposi’s sarcoma, thought to be driven at least in part by HHV8 proliferation related to the immunosuppression that accompanies transplantation, was recently reported to occur at a rate of approximately 2% after LT [13], similar to that in the HIV-TR report. All de novo KS lesions in the HIV-TR study were cutaneous, and all were treated successfully with the addition of rapamycin to the immunosuppressive regimen.…”
Section: Neoplasia After Transplantation In the Hiv Patientmentioning
confidence: 84%
“…4 Algunos informes de SK en trasplante hepático describen buena evolución con quimioterapia, con antivirales 14 o con conversión del tratamiento inmunosupresor a sirolimus. 6 En receptores adultos de trasplante renal, el sirolimus inhibió la progresión de SK y mantuvo, además, una inmunosupresión adecuada.…”
Section: Discussionunclassified